Curing Opioid Toxicity with Intrathecal Targeted Drug Delivery
Pain is one of the most feared symptoms that concern cancer patients and their families. Despite well-established guidelines set forth by the World Health Organization (WHO) on the treatment of cancer pain, nearly half of cancer patients report poorly controlled pain. One of the most serious side ef...
Main Authors: | Thomas P. Pittelkow, Markus A. Bendel, Jacob J. Strand, Susan M. Moeschler |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/3428576 |
Similar Items
-
High Cervical Intrathecal Targeted Drug Delivery: A Case Report of Refractory Oropharyngeal Cancer Pain
by: Rajat N. Moman, et al.
Published: (2019-01-01) -
Current perspectives on intrathecal drug delivery
by: Bottros MM, et al.
Published: (2014-11-01) -
Nanoparticle Drug Delivery to Brain Tumors: From Intravenous to Intrathecal
Published: (2018) -
Plain radiography in patients treated with intrathecal drug delivery using an implantable pump device
by: Elmar M. Delhaas, et al.
Published: (2017-08-01) -
Intrathecal catheterization and drug delivery in rats to compare the analgesic effects of morphine with ketorolac
by: Subrata Basu Ray, et al.
Published: (2011-01-01)